Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Argus Health
Boehringer Ingelheim
Queensland Health
Cantor Fitzgerald
Daiichi Sankyo
Moodys
UBS

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022345

« Back to Dashboard

NDA 022345 describes POTIGA, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. Additional details are available on the POTIGA profile page.

The generic ingredient in POTIGA is ezogabine. One supplier is listed for this compound. Additional details are available on the ezogabine profile page.
Summary for 022345
Tradename:POTIGA
Applicant:Glaxosmithkline
Ingredient:ezogabine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 022345
Mechanism of ActionPotassium Channel Openers
Suppliers and Packaging for NDA: 022345
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTIGA ezogabine TABLET;ORAL 022345 NDA GlaxoSmithKline LLC 0173-0810 N 0173-0810-59
POTIGA ezogabine TABLET;ORAL 022345 NDA GlaxoSmithKline LLC 0173-0812 N 0173-0812-59

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Jun 10, 2011TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Jun 10, 2011TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Jun 10, 2011TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Medtronic
Julphar
Deloitte
Boehringer Ingelheim
Citi
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.